{"text": "george kaiser family foundation has $1,239,000 stake in allergan plc. $agn URL"}
{"text": "$agn, $vrx, $vrx.ca - allergan to pay $15m over failing to disclose merger talks URL"}
{"text": "allergan to pay $15m over failure to disclose 2014 merger talks URL $agn #sitifatimah #malaysia #financialplanning"}
{"text": "marketcurrents: allergan to pay $15m over failure to disclose 2014 merger talks URL $agn"}
{"text": "rt AT_USER allergan to pay $15m over failure to disclose 2014 merger talks URL $agn"}
{"text": "allergan to pay $15m over failure to disclose 2014 merger talks URL $agn"}
{"text": "allergan to pay $15m over failure to disclose 2014 merger talks URL $agn"}
{"text": "#allergan to pay $15 million over failing to disclose merger talks. read more: URL $agn"}
{"text": "#allergan to pay $15 million over failing to disclose merger talks. read more: URL $agn"}
{"text": "#allergan to pay us$15 million over failing to disclose merger talks. read more: URL $agn"}
{"text": "#allergan to pay us$15 million over failing to disclose merger talks. read more: URL $agn"}
{"text": "#allergan to pay $15 mln over failing to disclose merger talks. read more: URL $agn"}
{"text": "#allergan paying $15 million penalty for disclosure failures during merger talks. read more: URL $agn"}
{"text": "#allergan to pay us$15 million over failing to disclose merger talks. read more: URL $agn"}
{"text": "#allergan to pay us$15 million over failing to disclose merger talks. read more: URL $agn"}
{"text": "#allergan to pay $15 mln over failing to disclose merger talks. read more: URL $agn"}
{"text": "#allergan paying $15 million penalty for disclosure failures during merger talks. read more: URL $agn"}
{"text": "rt AT_USER #sec hands $agn $15m speeding ticket for blowing off disclosure rules in vicious 2014 fight against valeant URL"}
{"text": "rt AT_USER #sec hands $agn $15m speeding ticket for blowing off disclosure rules in vicious 2014 fight against valeant URL"}
{"text": "#sec hands $agn $15m speeding ticket for blowing off disclosure rules in vicious 2014 fight against valeant URL #biotech"}
{"text": "rt AT_USER sec found $agn failed to disclose negotiations with other potential merger partners following offer from $vrx, co-bidders in ju\u00a1\u00ad"}
{"text": "rt AT_USER sec found $agn failed to disclose negotiations with other potential merger partners following offer from $vrx, co-bidders in ju\u00a1\u00ad"}
{"text": "rt AT_USER hitting now: us sec says found allergan failed to disclose talks with other potential merger partners after valeant offer i\u00a1\u00ad"}
{"text": "AT_USER $agn to pay $15m for disclosure failures during merger talks, co. admits to wrongdoing"}
{"text": "rt AT_USER sec found $agn failed to disclose negotiations with other potential merger partners following offer from $vrx, co-bidders in ju\u00a1\u00ad"}
{"text": "sec found $agn failed to disclose negotiations with other potential merger partners following offer from $vrx, co-bidders in jun. 2014"}
{"text": "$agn is looking to add the u.s. to its list of markets for ulipristal acetate URL"}
{"text": "$agn is looking to add the u.s. to its list of markets for ulipristal acetate URL"}
{"text": "hitting now: us sec says found allergan failed to disclose talks with other potential merger partners after valeant offer in 6/2014 $agn"}
{"text": "$agn calls...they pay again! nice dipper today.... #trade #stocks"}
{"text": "$agn sum put vol=2,696 sum call vol=3,894 putcallratio=0.69 expiration 01/20/2017 . URL URL"}
{"text": "rt AT_USER m&amp;a in 2016: pause for breath in a shifting market URL $shpg $pfe $abbv $agn URL"}
{"text": "teva revises outlook URL $agn $endp $jpm $myl $vrx $teva"}
{"text": "$agn allergan ceo: 2017 should be #kybella's breakout year URL via AT_USER"}
{"text": "oxbow advisors llc has $3,345,000 position in allergan plc. $agn URL"}
{"text": "allergan's esmya inches closer to u.s. approval, but fda label is key to its blockbuster fate: URL $agn #pharma"}
{"text": "$agn's #esmya inches closer to u.s. approval, but fda label is key to its blockbuster fate URL"}
{"text": "if AT_USER ditches #obamacare, it could help this drug-device developer \u00a1\u00aa and may hurt\u00a1\u00ad URL"}
{"text": "with its women's health products in an upswing, $agn announces new ph. 3 data URL"}
{"text": "with its women's health products in an upswing, $agn announces new ph. 3 data URL"}
{"text": "top sentiment for sp1500 stocks at midday: $ms $c $biib $agn $ba (2017/01/17) #sentiment #stock #alexandria"}
{"text": "special situation case study - paratek pharmaceuticals, inc. URL $agn $cemp $mrk $ttph $prtk"}
{"text": "special situation case study - paratek pharmaceuticals, inc. URL $agn $cemp $mrk $ttph $prtk"}
{"text": "dissecting and analyzing the special situation in paratek pharmaceuticals, inc URL $agn $cemp $mrk $ttph $prtk"}
{"text": "dissecting and analyzing the special situation in paratek pharmaceuticals, inc URL $agn $cemp $mrk $ttph $prtk"}
{"text": "#allergan's esmya inches closer to u.s. approval, but fda label is key to its blockbuster fate. read more: URL $agn"}
{"text": "#allergan's esmya inches closer to u.s. approval, but fda label is key to its blockbuster fate. read more: URL $agn"}
{"text": "rt AT_USER m&amp;a in 2016: pause for breath in a shifting market URL $shpg $pfe $abbv $agn URL"}
{"text": "that's it. pivot time. i'm moving out of atlanta. not sure where yet but i'm going! $vrx $agn $myl $mrk $ko $pep\u00a1\u00ad URL"}
{"text": "rt AT_USER m&amp;a in 2016: pause for breath in a shifting market URL $shpg $pfe $abbv $agn URL"}
{"text": "rt AT_USER m&amp;a in 2016: pause for breath in a shifting market URL $shpg $pfe $abbv $agn URL"}
{"text": "valeant's bucking the pharma mk up 2% $vrx $agn $myl $mrk $twtr $aapl $ko $pep $amgn $azn $teva #blue $srpt $nvs\u00a1\u00ad URL"}
{"text": "rt AT_USER m&amp;a in 2016: pause for breath in a shifting market URL $shpg $pfe $abbv $agn URL"}
{"text": "teva revises outlook URL $teva, $agn, $endp, $jpm, $myl, $vrx"}
{"text": "rt AT_USER m&amp;a in 2016: pause for breath in a shifting market URL $shpg $pfe $abbv $agn URL"}
{"text": "rt AT_USER committed to innovation in woman's health. positive phase iii results for ulipristal acetate $agn URL"}
{"text": "rt AT_USER m&amp;a in 2016: pause for breath in a shifting market URL $shpg $pfe $abbv $agn URL"}
{"text": "rt AT_USER committed to innovation in woman's health. positive phase iii results for ulipristal acetate $agn URL"}
{"text": "rt AT_USER m&amp;a in 2016: pause for breath in a shifting market URL $shpg $pfe $abbv $agn URL"}
{"text": "m&amp;a in 2016: pause for breath in a shifting market URL $shpg $pfe $abbv $agn URL"}
{"text": "rt AT_USER committed to innovation in woman's health. positive phase iii results for ulipristal acetate $agn URL"}
{"text": "rt AT_USER committed to innovation in woman's health. positive phase iii results for ulipristal acetate $agn URL"}
{"text": "rt AT_USER committed to innovation in woman's health. positive phase iii results for ulipristal acetate $agn URL"}
{"text": "AT_USER wanna conc on $cdtx.  still like $prtk.  hunch omc safer than eravacycline $ttph. wait 4 $agn-$prtk serac data/lt safety study."}
{"text": "must read: top trading &amp; investment resources. link: URL $ddd $agn $bhi $sap $gme $amlp $kite $pmcb $mtw $cxo"}
{"text": "positive phase iii results for #allergan and gedeon richter. read more: URL $agn"}
{"text": "positive phase iii results for #allergan and gedeon richter. read more: URL $agn"}
{"text": "top #sentiment for #sp1500 #stocks at market open: $ms $agn $rai $bk $fe (2017/01/17) #stocktrading #predictiveanalytics #bigdata"}
{"text": "top sentiment for sp1500 stocks at market open: $ms $agn $rai $bk $fe (2017/01/17) #sentiment #stock #alexandria"}
{"text": "#allergan, gedeon richter show off late-stage uterine fibroids data  . read more: URL $agn"}
{"text": "#allergan, gedeon richter show off late-stage uterine fibroids data  . read more: URL $agn"}
{"text": "rt AT_USER commented on the threats and opportunities in nash: what next for allergan? URL $gnftf $icpt $gild $nvo\u00a1\u00ad"}
{"text": "rt AT_USER committed to innovation in woman's health. positive phase iii results for ulipristal acetate $agn URL"}
{"text": "$agn aces another promising phiii on uterine fibroid therapy, with plans to hustle the bundle to the fda - URL AT_USER"}
{"text": "rt AT_USER commented on the threats and opportunities in nash: what next for allergan? URL $gnftf $icpt $gild $nvo\u00a1\u00ad"}
{"text": "commented on the threats and opportunities in nash: what next for allergan? URL $gnftf $icpt $gild $nvo $agn"}
{"text": "rt AT_USER committed to innovation in woman's health. positive phase iii results for ulipristal acetate $agn URL"}
{"text": "120% upside to sarepta shares $srpt $ko $pep $ipxl $bbib $vrx $agn $myl $mrk $jnj $gild $amgn $blue $spy $qqq $iep\u00a1\u00ad URL"}
{"text": "teva revises outlook URL $agn $endp $jpm $myl $vrx $teva"}
{"text": "rt AT_USER committed to innovation in woman's health. positive phase iii results for ulipristal acetate $agn URL"}
{"text": "spears abacus advisors llc has $31,961,000 stake in allergan plc. $agn URL"}
{"text": "rt AT_USER second late-stage study of uterine fibroid treatment successful; allergan to submit u.s. marketin... URL"}
{"text": "second late-stage study of uterine fibroid treatment successful; allergan to submit u.s. marketin... URL #premarket $agn"}
{"text": "second late-stage study of uterine fibroid treatment successful; allergan to submit u.s. marketin... URL #premarket $agn"}
{"text": "rt AT_USER had the best trading week of my life. nearly 40k in one week. mostly due to $agn $aapl $fb &amp; $amzn #stocks #trading URL"}
{"text": "URL on track to exceed not only my AT_USER $srptw article AT_USER  $vrx $agn $aapl $myl $mrk $iep $hlf $ko"}
{"text": "i'm on the first page now. :-) AT_USER AT_USER  $vrx $agn $twtr $aapl $ko $pep $myl $mrk $iep $hlf\u00a1\u00ad URL"}
{"text": "#allergan plans to file oral uterine fibroid drug in us by yearend. read more: URL $agn"}
{"text": "#allergan plans to file oral uterine fibroid drug in us by yearend. read more: URL $agn"}
{"text": "committed to innovation in woman's health. positive phase iii results for ulipristal acetate $agn URL"}
{"text": "#allergan plans to file oral uterine fibroid drug in us by year-end. read more: URL $agn"}
{"text": "#allergan plans to file oral uterine fibroid drug in us by year-end. read more: URL $agn"}
{"text": "richter gedeon vegyeszeti gyar : #allergan and richter announce positive phase iii results f... read more: URL $agn"}
{"text": "richter gedeon vegyeszeti gyar : #allergan and richter announce positive phase iii results f... read more: URL $agn"}
{"text": "brief-richter, #allergan announce positive uterine fibroid medicine test. read more: URL $agn"}
{"text": "brief-#allergan and gedeon richter announce positive phase iii results for ulipristal acetat... read more: URL $agn"}
{"text": "brief-richter, #allergan announce positive uterine fibroid medicine test. read more: URL $agn"}
{"text": "brief-#allergan and gedeon richter announce positive phase iii results for ulipristal acetat... read more: URL $agn"}
{"text": "$agn +ve fibroid ph3  URL"}
{"text": "$agn says study met all co-primary and secondary endpoints with both treatment arms achieving statistically significant results over placebo"}
